Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences Ltd has submitted the notice for its 40th Annual General Meeting scheduled for Tuesday, 23rd September 2025, in compliance with SEBI Listing Regulations. The AGM will address ordinary business including adoption of audited financial statements for FY ended March 31, 2025, and re-appointment of a director retiring by rotation. The agenda also includes special resolutions to enhance the company's borrowing limit under Section 180(1)(c) to up to Rs 100 crores, and to approve investments, loans and guarantees up to Rs 100 crores under Section 186 of the Companies Act, 2013. Note: The attached AGM notice text refers to a different entity, 'Shree Ganesh Bio-Tech (India) Limited' (15th AGM, 26th September 2025), which appears to be a clerical error or mismatch in the filing. Remote e-voting facility via NSDL is being provided, with the cut-off date being 19th September 2025.
For shareholders, this is a procedural filing but signals that two special business items will require their vote: expansion of the borrowing cap to Rs 100 crore and broader investment/lending powers up to Rs 100 crore, indicating the company may be seeking flexibility for future debt or related-party transactions. The mismatch between the covering company name and the enclosed notice content is a red flag worth flagging to the company for clarification before the AGM.